{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:16:34Z","timestamp":1792131394906,"version":"4.4.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.survophthal.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:00:06Z","timestamp":1550145606000},"page":"608-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Current treatment and management of infantile hemangiomas"],"prefix":"10.1016","volume":"64","author":[{"given":"Kellie R.","family":"Satterfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3630-2839","authenticated-orcid":false,"given":"Christopher B.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2014.01.905","article-title":"Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study","volume":"70","author":"\u00c1barz\u00faa-Araya","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/bjd.12432","article-title":"Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol","volume":"169","author":"Ahogo","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000069960","article-title":"Early Treatment of Hemangiomas with Lasers","volume":"206","author":"Al Buainian","year":"2003","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ophtha.2010.10.031","article-title":"Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children","volume":"118","author":"Al Dhaybi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.02.005_bib5","article-title":"Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double-blind randomized controlled trial","volume":"4","author":"Asilian","year":"2015","journal-title":"Adv Biomed Res"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0974-9233.63071","article-title":"Periocular capillary hemangiomas: indications and options for treatment","volume":"17","author":"Bang","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2230.2007.02676.x","article-title":"Involution of infantile haemangiomas after imiquimod 5% cream","volume":"33","author":"Barry","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"10.1016\/j.survophthal.2019.02.005_bib8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamadermatol.2016.2905","article-title":"Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy","volume":"152","author":"Baselga","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","article-title":"Untreated hemangiomas: growth pattern and residual lesions","volume":"127","author":"Bauland","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pde.12420","article-title":"Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol","volume":"31","author":"Beal","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ijd.12489","article-title":"PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety","volume":"54","author":"Bellaud","year":"2015","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/pde.12686","article-title":"Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol","volume":"32","author":"Bernabeu-Wittel","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.survophthal.2019.02.005_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0009922811405517","article-title":"\u03b2-blockers for infantile hemangiomas: a single-institution experience","volume":"50","author":"Blatt","year":"2011","journal-title":"Clin Pediatr"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/00006534-199911000-00002","article-title":"Complications of systemic corticosteroid therapy for problematic hemangioma","volume":"104","author":"Boon","year":"1999","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archderm.1960.01580050009002","article-title":"The Natural History of the Strawberry Nevus","volume":"82","author":"Bowers","year":"1960","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pd.1970150302","article-title":"An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS)","volume":"15","author":"Burton","year":"1995","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/bjd.12417","article-title":"Propranolol-resistant infantile haemangiomas","volume":"169","author":"Causs\u00e9","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0736-8046.2004.21101.x","article-title":"Periocular hemangiomas: what every physician should know","volume":"21","author":"Ceisler","year":"2004","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/IOP.0b013e31823bfffb","article-title":"A\u00a0Controlled Study of Topical 0.25% Timolol Maleate Gel for the Treatment of Cutaneous Infantile Capillary Hemangiomas","volume":"28","author":"Chambers","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1442-200X.2008.02770.x","article-title":"Interferon-alpha for alarming hemangiomas in infants: experience of a single institution","volume":"51","author":"Chao","year":"2009","journal-title":"Pediatr Int"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3468(00)90205-7","article-title":"Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases","volume":"35","author":"Chen","year":"2000","journal-title":"J\u00a0Pediatr Surg"},{"issue":"12","key":"10.1016\/j.survophthal.2019.02.005_bib22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archderm.138.12.1567","article-title":"Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex","volume":"138","author":"Chiller","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib23","doi-asserted-by":"crossref","first-page":"e20153896","DOI":"10.1542\/peds.2015-3896","article-title":"Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis","volume":"137","author":"Chinnadurai","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/lsm.22455","article-title":"Laser treatment of infantile hemangioma: A systematic review","volume":"48","author":"Chinnadurai","year":"2015","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1096-9101(1998)23:4<221::AID-LSM5>3.0.CO;2-A","article-title":"Laser treatment of hemangiomas of the larynx and trachea","volume":"23","author":"Cholewa","year":"1998","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/SCS.0000000000001561","article-title":"Surgical Management of Scalp Infantile Hemangiomas","volume":"26","author":"Cho","year":"2015","journal-title":"J\u00a0Craniofac Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1440-0960.2012.00901.x","article-title":"Effect of captopril on infantile haemangiomas: a retrospective case series","volume":"53","author":"Christou","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"12","key":"10.1016\/j.survophthal.2019.02.005_bib28","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bjps.2007.09.027","article-title":"Use of ultrasonic dissection in the early surgical management of periorbital haemangiomas","volume":"61","author":"Claude","year":"2008","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2007-991184","article-title":"Laser Treatment of Pediatric Vascular Lesions","volume":"21","author":"Cole","year":"2007","journal-title":"Semin Plast Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PRS.0b013e31825dc129","article-title":"Infantile hemangioma: clinical assessment of the involuting phase and implications for management","volume":"130","author":"Couto","year":"2012","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000448396","article-title":"Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases","volume":"232","author":"Danarti","year":"2016","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib32","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1542\/peds.2015-2485","article-title":"Diagnosis and Management of Infantile Hemangioma","volume":"136","author":"Darrow","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib33","first-page":"475","article-title":"Hemangiomas: evaluation and treatment","volume":"27","author":"Dinehart","year":"2001","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM199907153410307","article-title":"Hemangiomas in Children","volume":"341","author":"Drolet","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference","volume":"131","author":"Drolet","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1525-1470.1993.tb00393.x","article-title":"The Current Management of Vascular Birthmarks","volume":"10","author":"Enjolras","year":"1993","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1542\/peds.85.4.491","article-title":"Management of alarming hemangiomas in infancy: a review of 25 cases","volume":"85","author":"Enjolras","year":"1990","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1525-1470.1992.tb00628.x","article-title":"Hemangiomas in infants and children: clinical observations","volume":"9","author":"Esterly","year":"1992","journal-title":"Pediatr Dermatol"},{"issue":"22","key":"10.1016\/j.survophthal.2019.02.005_bib39","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bjps.2003.11.003","article-title":"Vincristine as a treatment for a large haemangioma threatening vital functions","volume":"57","author":"Fawcett","year":"2004","journal-title":"Br J Plast Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archophthalmol.2009.375","article-title":"Propranolol for isolated orbital infantile hemangioma","volume":"128","author":"Fay","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2019.02.005_bib42","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/pbc.24543","article-title":"Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon","volume":"60","author":"Fernandez-Pineda","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4330\/wjc.v8.i1.74","article-title":"Cardiovascular drugs in the treatment of infantile hemangioma","volume":"8","author":"Fernandez-Pineda","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.survophthal.2019.02.005_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijporl.2016.02.005","article-title":"Use of intravenous propranolol for control of a large cervicofacial hemangioma in a critically ill neonate","volume":"84","author":"Fernando","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.survophthal.2019.02.005_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00383-015-3716-x","article-title":"Negative pressure wound therapy in the treatment of ulcerated infantile haemangioma","volume":"31","author":"Fox","year":"2015","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bjps.2008.08.045","article-title":"Visual development in infants: visual complications of periocular haemangiomas","volume":"63","author":"Frank","year":"2010","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib47","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1525-1470.2008.00781_3.x","article-title":"Addendum: Commentary on becaplermin gel (Regranex) for hemangiomas","volume":"25","author":"Frieden","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.survophthal.2019.02.005_bib48","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archderm.1997.03890480119022","article-title":"Which hemangiomas to treat--and how?","volume":"133","author":"Frieden","year":"1997","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0190-9622(97)70183-X","article-title":"The Guidelines\/Outcomes Committee*. Guidelines of care for hemangiomas of infancy","volume":"37","author":"Frieden","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archderm.1996.03890270083012","article-title":"PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities","volume":"132","author":"Frieden","year":"1996","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/pde.12869","article-title":"Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma","volume":"33","author":"Frommelt","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaad.2004.09.004","article-title":"Ultrapotent topical corticosteroid treatment of hemangiomas of infancy","volume":"52","author":"Garzon","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib53","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1111\/pde.12868","article-title":"Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma","volume":"33","author":"Gill","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib54","first-page":"95","article-title":"Adrenal suppression and growth retardation after injection of periocular capillary hemangioma with corticosteroids","volume":"22","author":"Glatt","year":"1991","journal-title":"Ophthalmic Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/ajd.12156","article-title":"Retrospective follow up of gross motor development in children using propranolol for treatment of infantile haemangioma at Sydney Children's Hospital","volume":"55","author":"Gonski","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0161-6420(03)00833-9","article-title":"Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma","volume":"111","author":"Goyal","year":"2004","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2019.02.005_bib57","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0903036","article-title":"Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells","volume":"362","author":"Greenberger","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1523-1747.ep12482476","article-title":"Comparative histological studies of the tunable dye (at 577 nm) laser and argon laser: the specific vascular effects of the dye laser","volume":"77","author":"Greenwald","year":"1981","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archophthalmol.2009.370","article-title":"Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution","volume":"128","author":"Guo","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archdermatol.2011.926","article-title":"Measuring the severity of infantile hemangiomas: instrument development and reliability","volume":"148","author":"Haggstrom","year":"2012","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib61","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.2006-0413","article-title":"Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment","volume":"118","author":"Haggstrom","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib62","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1542\/peds.2005-1092","article-title":"Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development","volume":"117","author":"Haggstrom","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib63","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0161-6420(79)35452-5","article-title":"Capillary Hemangioma of the Lids and Orbit: An Analysis of The Clinical Features and Therapeutic Results in 101 Cases","volume":"86","author":"Haik","year":"1979","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00043426-200208000-00010","article-title":"Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine","volume":"24","author":"Haisley-Royster","year":"2002","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib65","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/pde.12681","article-title":"Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 Infants","volume":"32","author":"Hengst","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajmg.1320210127","article-title":"Sternal malformation\/vascular dysplasia association","volume":"21","author":"Hersh","year":"1985","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib67","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","article-title":"A\u00a0randomized controlled trial of propranolol for infantile hemangiomas","volume":"128","author":"Hogeling","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib68","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.pcl.2010.07.008","article-title":"Infantile Hemangioma","volume":"57","author":"Holland","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.survophthal.2019.02.005_bib69","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/205410s000lbl.pdf. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/205410s000lbl.pdf. Accessed February 13,\u00a02018."},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000369164","article-title":"Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma","volume":"230","author":"Hu","year":"2015","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib71","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jclinpath-2014-202794","article-title":"Angiotensin II causes cellular proliferation in infantile haemangioma via angiotensin II receptor 2 activation","volume":"68","author":"Itinteang","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"issue":"8 Pt 1","key":"10.1016\/j.survophthal.2019.02.005_bib72","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00042728-200508000-00002","article-title":"Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes","volume":"31","author":"Iyer","year":"2005","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaad.2015.05.015","article-title":"Experience with Holter monitoring during propranolol therapy for infantile hemangiomas","volume":"73","author":"Jacks","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00383-011-3037-7","article-title":"Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol","volume":"28","author":"Janmohamed","year":"2012","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2015.05.012","article-title":"Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS)","volume":"73","author":"Janmohamed","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib76","first-page":"640","article-title":"Treatment with interferon-alpha-2b in children with life-threatening hemangiomas","volume":"34","author":"Jim\u00e9nez-Hern\u00e1ndez","year":"2008","journal-title":"Dermatol Surg"},{"issue":"24","key":"10.1016\/j.survophthal.2019.02.005_bib77","doi-asserted-by":"crossref","first-page":"e3908","DOI":"10.1097\/MD.0000000000003908","article-title":"Oral atenolol therapy for proliferating infantile hemangioma: A prospective study","volume":"95","author":"Ji","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib78","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9394(88)90913-0","article-title":"Diseases of the Orbit. A Multidisciplinary Approach","volume":"106","author":"Kennerdell","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.02.005_bib79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/dsu.12081","article-title":"Superficial hemangioma: pulsed dye laser versus wait-and-see","volume":"39","author":"Kessels","year":"2013","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1525-1470.2008.00626.x","article-title":"Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature","volume":"25","author":"Kilcline","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib81","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mjd.2001.112382","article-title":"Ulcerated hemangiomas: clinical characteristics and response to therapy","volume":"44","author":"Kim","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib82","doi-asserted-by":"crossref","first-page":"e979699","DOI":"10.4161\/19381980.2014.979699","article-title":"Mechanisms of propranolol action in infantile hemangioma","volume":"6","author":"Kum","year":"2014","journal-title":"Dermatoendocrinol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/dsu.12451","article-title":"Effect of early long-pulse pulsed dye laser treatment in infantile hemangiomas","volume":"40","author":"Kwon","year":"2014","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib84","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","article-title":"Propranolol treatment for hemangioma of infancy: risks and recommendations","volume":"26","author":"Lawley","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"24","key":"10.1016\/j.survophthal.2019.02.005_bib85","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.survophthal.2019.02.005_bib86","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A\u00a0randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-1470.2006.00207.x","article-title":"Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas-- a retrospective study","volume":"23","author":"Lomenick","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3928\/01913913-20170703-12","article-title":"Combined oral and topical beta blockers for the treatment of early proliferative superficial periocular infantile capillary hemangioma","volume":"55","author":"Marey","year":"2018","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ijd.13517","article-title":"Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas","volume":"56","author":"Mashiah","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2019.02.005_bib90","series-title":"Hemangiomas and Vascular Malformations: An Atlas of Diagnosis and Treatment","author":"Mattassi","year":"2010"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-1470.2008.00857.x","article-title":"A\u00a0Phase II, Open-Label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma","volume":"26","author":"McCuaig","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"10.1016\/j.survophthal.2019.02.005_bib92","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.136.7.905","article-title":"Benign cutaneous vascular tumors of infancy","volume":"136","author":"Metry","year":"2000","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.survophthal.2019.02.005_bib93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.140.7.867","article-title":"Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor","volume":"140","author":"Metz","year":"2004","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.survophthal.2019.02.005_bib94","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00005537-200407000-00017","article-title":"Spastic diplegia and other motor disturbances in infants receiving interferon-alpha","volume":"114","author":"Michaud","year":"2004","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.survophthal.2019.02.005_bib95","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/jpsu.2001.25793","article-title":"Effective therapy of a vascular tumor of infancy with vincristine","volume":"36","author":"Moore","year":"2001","journal-title":"J\u00a0Pediatr Surg"},{"issue":"26","key":"10.1016\/j.survophthal.2019.02.005_bib96","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1056\/NEJMc086443","article-title":"More on Propranolol for Hemangiomas of Infancy","volume":"359","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2015.04.053","article-title":"Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor\u00a0development","volume":"73","author":"Moyakine","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2016.02.1218","article-title":"Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years","volume":"75","author":"Moyakine","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.survophthal.2019.02.005_bib99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0011-3840(00)80013-1","article-title":"Vascular anomalies","volume":"37","author":"Mulliken","year":"2000","journal-title":"Curr Probl Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/SAP.0000000000000521","article-title":"Propranolol therapy for problematic infantile hemangioma","volume":"76","author":"Ng","year":"2016","journal-title":"Ann Plast Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib101","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archophthalmol.2011.24","article-title":"Topical timolol for periocular hemangioma: report of further study","volume":"129","author":"Ni","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/SAP.0000000000000390","article-title":"Local administration of \u03b2-blockers for infantile hemangiomas: a systematic review and meta-analysis","volume":"74","author":"Ovadia","year":"2015","journal-title":"Ann Plast Surg"},{"issue":"11","key":"10.1016\/j.survophthal.2019.02.005_bib103","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/ped.12981","article-title":"Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor","volume":"58","author":"Ozeki","year":"2016","journal-title":"Pediatr Int"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib104","first-page":"172","article-title":"Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas","volume":"20","author":"Painter","year":"2016","journal-title":"J\u00a0AAPOS"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/lsm.20245","article-title":"Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser","volume":"38","author":"Parlette","year":"2006","journal-title":"Lasers Surg Med"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/028418602753669607","article-title":"Vincristine--an effective treatment of corticoid-resistant life-threatening infantile hemangiomas","volume":"41","author":"Perez","year":"2002","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2012.11131.x","article-title":"Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol","volume":"168","author":"Pope","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib108","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2015.13969","article-title":"Safety of Propranolol Therapy for Severe Infantile Hemangioma","volume":"315","author":"Prey","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib109","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0355","article-title":"Topical Timolol Maleate Treatment of Infantile Hemangiomas","volume":"138","author":"P\u00fcttgen","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/pde.12422","article-title":"Eighteen cases of soft tissue atrophy after Intralesional Bleomycin A5 Injections for the treatment of infantile hemangiomas: A Long-Term Follow-Up","volume":"32","author":"Qiu","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib111","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/pde.12002","article-title":"Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars","volume":"30","author":"Qiu","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib112","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(05)83420-1","article-title":"Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations","volume":"122","author":"Reese","year":"1993","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib113","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ijd.13442","article-title":"Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol","volume":"56","author":"Rotter","year":"2016","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib114","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/abd1806-4841.20187693","article-title":"PHACE syndrome: clinical manifestations, diagnostic criteria, and management","volume":"93","author":"Rotter","year":"2018","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib115","first-page":"365","article-title":"Long-Term Results with a Multiple Synchronized-Pulse 1064 nm Nd:YAG Laser for the Treatment of Leg Venulectasias and Reticular Veins","volume":"27","author":"Sadick","year":"2001","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib116","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile hemangiomas: follow-up report","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib117","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2310\/7750.2012.11113","article-title":"Early surgical excision of giant congenital hemangiomas of the scalp in newborns: clinical indications and reconstructive aspects","volume":"17","author":"Santecchia","year":"2013","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archfaci.2011.32","article-title":"Excision of periorbital hemangiomas to correct visual abnormalities","volume":"13","author":"Schneider","year":"2011","journal-title":"Arch Facial Plast Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib119","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/092986707780059625","article-title":"The antitumoral mode of action of imiquimod and other imidazoquinolines","volume":"14","author":"Sch\u00f6n","year":"2007","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/v10249-011-0046-4","article-title":"Topical Treatment of Infantile Hemangiomas \u2013 Where Are We Now?\/Topikalni tretman infantilnih hemangioma \u2013 gde smo danas?","volume":"3","author":"Semkova","year":"2011","journal-title":"Serbian J Dermatol Venerology"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib121","first-page":"E21","article-title":"Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases","volume":"89","author":"Senchak","year":"2010","journal-title":"Ear Nose Throat J"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib122","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1754","article-title":"Rebound growth of infantile hemangiomas after propranolol therapy","volume":"137","author":"Shah","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib123","first-page":"229","article-title":"Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma","volume":"17","author":"Shorr","year":"1986","journal-title":"Ophthalmic Surg"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib124","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1442-9071.2003.00689.x","article-title":"Early surgical intervention as definitive treatment for ocular adnexal capillary haemangioma","volume":"31","author":"Slaughter","year":"2003","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2019.02.005_bib125","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/eye.2011.164","article-title":"The use of propranolol in the management of periocular capillary haemangioma\u2014a systematic review","volume":"25","author":"Spiteri Cornish","year":"2011","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2007.10.492","article-title":"Laser treatment of pediatric vascular lesions: Port wine stains and hemangiomas","volume":"58","author":"Stier","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib127","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9394(14)78109-7","article-title":"Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit","volume":"85","author":"Stigmar","year":"1978","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.138.3.314","article-title":"Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor","volume":"138","author":"Sugarman","year":"2002","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bjps.2015.10.020","article-title":"Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma","volume":"69","author":"Sulzberger","year":"2016","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib130","first-page":"103","article-title":"Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma","volume":"18","author":"Sutula","year":"1987","journal-title":"Ophthalmic Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ophtha.2009.08.040","article-title":"Propranolol for orbital hemangioma","volume":"117","author":"Taban","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2019.02.005_bib132","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","article-title":"Cellular markers that distinguish the phases of hemangioma during infancy and childhood","volume":"93","author":"Takahashi","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.survophthal.2019.02.005_bib133","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bjophthalmol-2015-307284","article-title":"Predicting complications with pretreatment testing in infantile haemangioma treated with oral propranolol","volume":"100","author":"Tang","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib134","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11596-015-1503-5","article-title":"Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas","volume":"35","author":"Tang","year":"2015","journal-title":"J\u00a0Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2003.582","article-title":"Lasers in dermatology: Four decades of progress","volume":"49","author":"Tanzi","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib136","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/ped.12618","article-title":"Successful treatment by coil embolization for infantile hemangioma with Kasabach-Meritt syndrome of newborn","volume":"57","author":"Tezuka","year":"2015","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10006-015-0528-z","article-title":"Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study","volume":"20","author":"Tiwari","year":"2016","journal-title":"Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib138","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/jocd.12220","article-title":"Treatment with propranolol for infantile hemangiomas: single-center experience","volume":"15","author":"Turhan","year":"2016","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib139","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/pde.12520","article-title":"Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase","volume":"32","author":"Vivas-Colmenares","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.survophthal.2019.02.005_bib140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-8628(19990101)82:1<77::AID-AJMG15>3.0.CO;2-A","article-title":"Genetic mapping of a novel familial form of infantile hemangioma","volume":"82","author":"Walter","year":"1999","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib141","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/pde.12767","article-title":"Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption","volume":"33","author":"Weibel","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.survophthal.2019.02.005_bib142","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0002-9394(89)90497-2","article-title":"Adrenal suppression after corticosteroid injection of periocular hemangiomas","volume":"107","author":"Weiss","year":"1989","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2019.02.005_bib143","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2004.04.022","article-title":"Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream","volume":"51","author":"Welsh","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.survophthal.2019.02.005_bib144","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaophthalmol.2013.4171","article-title":"Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops","volume":"131","author":"Xue","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jaad.2004.10.876","article-title":"Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for port-wine stains","volume":"52","author":"Yang","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2019.02.005_bib146","series-title":"Vascular Lesions of the Orbit and Face: Imaging and Management","author":"Yen","year":"2016"},{"issue":"3","key":"10.1016\/j.survophthal.2019.02.005_bib147","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2015.09.061","article-title":"Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial","volume":"74","author":"Zaher","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.survophthal.2019.02.005_bib148","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14764172.2016.1197402","article-title":"Hemangioma treatment with pulsed dye laser-distinct parameters used between neonatal and non-neonatal patients","volume":"18","author":"Zhang","year":"2016","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"10","key":"10.1016\/j.survophthal.2019.02.005_bib149","first-page":"851","article-title":"A\u00a0practical guide to treatment of infantile hemangiomas of the head and neck","volume":"6","author":"Zheng","year":"2013","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"10.1016\/j.survophthal.2019.02.005_bib150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1525-1470.2010.01379.x","article-title":"Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study","volume":"28","author":"Zvulunov","year":"2011","journal-title":"Pediatr Dermatol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625718300614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625718300614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:47:53Z","timestamp":1758541673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625718300614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0039625718300614"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2019.02.005","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current treatment and management of infantile hemangiomas","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}